Clinical Trial Update: PE PREMIER CHINA CLINICAL TRIAL [NA]

View source ↗

Summary

Clinical trial update for the PE PREMIER China trial completed; results posted in 2022. No disease-specific outcomes detailed in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• PE PREMIER China trial

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atherosclerosis | NA | Status: COMPLETED | Results posted: 2022-05-12